Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Éric de Chassey on Simon Hantaï
View through CrossRef
Abstract
This is a transcript of an interview with Éric de Chassey conducted by Mick Finch on the occasion of the Simon Hantaï exhibition curated by de Chassey at the Villa Médici in Rome between the 12 February to 11 May 2014. De Chassey is Professor of Art History at the Ecole Normale Supérieure in Lyons and has, since 2009, been the Director of the French Academy in Rome, the Villa Medici. The Villa Medici exhibition took place after the major Hantaï exhibition at the Centre Pompidou in 2013 for which de Chassey had contributed an catalogue essay on Hantaï’s silkscreen work. The interview discusses the context of the Villa Medici exhibition and particuarly the way Hantaï’s latter years were represented. The interview took place at the Villa Medici on Sunday 11 May 2014.
Title: Éric de Chassey on Simon Hantaï
Description:
Abstract
This is a transcript of an interview with Éric de Chassey conducted by Mick Finch on the occasion of the Simon Hantaï exhibition curated by de Chassey at the Villa Médici in Rome between the 12 February to 11 May 2014.
De Chassey is Professor of Art History at the Ecole Normale Supérieure in Lyons and has, since 2009, been the Director of the French Academy in Rome, the Villa Medici.
The Villa Medici exhibition took place after the major Hantaï exhibition at the Centre Pompidou in 2013 for which de Chassey had contributed an catalogue essay on Hantaï’s silkscreen work.
The interview discusses the context of the Villa Medici exhibition and particuarly the way Hantaï’s latter years were represented.
The interview took place at the Villa Medici on Sunday 11 May 2014.
Related Results
Reflections on Simon Hantaï: Daniel Buren in conversation with Daniel Sturgis, Varennes-Jarcy, 23 September 2014
Reflections on Simon Hantaï: Daniel Buren in conversation with Daniel Sturgis, Varennes-Jarcy, 23 September 2014
Abstract
This article, in the form of a conversation between Daniel Buren and Daniel Sturgis, reflects upon Daniel Buren’s friendship and respect for the work of Sim...
Physicochemistry of artists' materials from the second half of the 20th century : Studying artists' products from the workshop of the painter Simon Hantaï
Physicochemistry of artists' materials from the second half of the 20th century : Studying artists' products from the workshop of the painter Simon Hantaï
Physico-chimie de matériaux d'artistes de la seconde moitié du 20e siècle : Étude de produits d'artistes provenant de l'atelier du peintre Simon Hantaï
Les matériau...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Le camp de Chassey (Chassey-le-Camp, Saône-et-Loire)
Le camp de Chassey (Chassey-le-Camp, Saône-et-Loire)
Le présent ouvrage rend compte des fouilles menées durant onze années dans le gisement pré- et protohistorique du camp de Chassey, site de la région chalonnaise éponyme d’une cultu...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract
The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background:
Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
HX32 Karl Gustav Theodor Simon (1810–1857): ‘the father of dermatopathology’
HX32 Karl Gustav Theodor Simon (1810–1857): ‘the father of dermatopathology’
Abstract
Karl Gustav Theodor Simon (1810–1857) was a pioneering pathologist and dermatologist who is widely regarded as the ‘father of dermatopathology’. Simon comme...